Robert Radloff
Robert Radloff
Contributor, The Yuan

Robert Radloff has more than ten years of experience in the pharmaceutical and medical device industries. His interests lie in digitization and artificial intelligence solutions. His startup "Curedatis" supports life science and pharma companies in the systematic literature review process to turn data into treatment.

The future of AI chatbots as digital therapists
Game-changers
AI and ML have led to many healthcare advancements. Robert Radloff, whose startup Curedatis helps life science and pharma firms turn data into treatment, talks chatbots used in mental health interventions, their benefits, and risks in diagnosing and treating mental health issues.
Robert Radloff  |  Mar 08, 2023